By - Reuters
March 20 (Reuters) - Enlivex Therapeutics Ltd:
* ENLIVEX RECEIVES POSITIVE DSMB RECOMMENDATION AND IMOH CLEARANCE TO CONTINUE PHASE I/II TRIAL OF ALLOCETRA COMBINED WITH CHEMOTHERAPY IN PATIENTS WITH PERITONEAL METASTASES ARISING FROM SOLID CANCERS
* ENLIVEX THERAPEUTICS LTD - THERE WERE NO MORTALITIES NOR DSMB-IDENTIFIED SAFETY SIGNALS IN FIRST COHORT Source text for Eikon: Further company coverage: